Understand Every Side.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Champions League
South America
Social Media
Motorsports
Soccer
Cricket
Baseball
Latin America
WWE
US Politics
Artificial Intelligence
Natural Disasters
Published • loading... • Updated

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)

Summary by Ground News
The U.S. Department of Veterans Affairs (VA) is launching new studies on using psychedelic compounds to treat post-traumatic stress disorder (PTSD) and depression among military veterans. This new VA-backed effort will delve deeper into "the effectiveness and safety of using MDMA and psilocybin-augmented psychotherapy in veterans"

1 Articles

All
Left
Center
1
Right
BenzingaBenzinga
Center

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Public Benefit Corporation has secured over $100 million in a Series A private stock sale. The funds will support the final stages of its application for regulatory approval to sell MDMA, also known as ecstasy, as a t…

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Friday, January 12, 2024.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal